Delivery Order SPE2DB22D3009-SPE2DB25FAR34
Award Date
2/13/25
Potential Completion Date
2/14/25
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with the ID SPE2DX15D3005|SPE2DX24F3SPG, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,187.00, is a Firm Fixed Price Delivery Order for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a medical product. The contract has a period of performance through July 5, 2024. Amerisourcebergen Drug Corp is the prime contractor...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,366.55 Firm Fixed Price Delivery Order contract is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, with an ultimate completion date of October 25, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,292.36 Firm Fixed Price Delivery Order (SPE2DB22D2211) is for the supply of BIMZELX 160 MG/ML AUTOINJECTOR, a specialty medication, with a completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,374.03, is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a specialty pharmaceutical product. The contract has an ultimate completion date of February 18, 2025 and is a firm fixed-price contract. This contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $61,765.98, is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a specialty pharmaceutical product. The contract has a firm-fixed price pricing type and an ultimate completion date of July 3, 2024. The contract is not designated with any set-aside requirements, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the delivery of BIMZELX 160 MG/ML AUTOINJECTORML medical supplies. The contract has a ceiling value of $49,184.69 and an ultimate completion date of September 13, 2024. It is a Firm Fixed Price Delivery Order contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,453.05 firm fixed-price contract is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of January 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,108.93, is for the delivery of BIMZELX 160 MG/ML AUTOINJECTORML, a specialty medication. The contract has a completion date of July 29, 2024 and is a Firm Fixed Price contract. There is no set-aside designation indicated for this award. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, with an ID of SPE2DB20D2104|SPE2DB25FMGVG, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,802.33 firm-fixed-price delivery order covers the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a medical product, to support federal healthcare programs. The contract is not designated as a set-aside and serves as a delivery order under AmerisourceBergen's existing...
The federal contract award is for the delivery of BIMZELX 160 MG/ML AUTOINJECTOR medication to the Defense Logistics Agency (DLA), a defense agency. The contract, worth $9,982.88, is a Firm Fixed Price Delivery Order with AmerisourceBergen Drug Corp as the prime contractor. The contract has an ultimate completion date of November 13, 2024 and was awarded on November 12, 2024. The place of performance is Conshohocken, PA. This contract award is part of a larger Indefinite Delivery Contract...